文献速递乳腺MR

术前乳腺MRI对35岁及以下乳腺癌患者生存结局的影响

Effects of Preoperative Breast MRI on Breast Cancer Survival Outcomes in Women Aged 35 Years and Younger.
PubMed 文献 · Radiology · 2023-03-28

回顾性纳入708例35岁及以下乳腺癌患者,按23项特征倾向性评分匹配125对,比较术前MRI组与非MRI组的无复发生存和总生存;匹配后两组总复发、局部区域复发、对侧复发及远处复发均无显著差异,MRI组总生存有改善趋势但无统计学意义。

要点

  • 匹配后术前乳腺MRI未显著改善无复发生存。
  • MRI组总生存有改善趋势但无统计学意义。
  • 研究不支持术前MRI作为该人群常规预后改善手段。

核心结论

  • 术前乳腺MRI不是35岁及以下乳腺癌患者无复发生存的显著预后因素。
  • MRI组总生存有改善趋势但未达统计学意义。

研究设计与样本

  • 回顾性识别2007至2016年诊断的708例35岁及以下乳腺癌女性,平均年龄32岁±3。
  • 按23项患者和肿瘤特征进行倾向性评分匹配,得到125对MRI组与无MRI组。
  • 采用Kaplan-Meier法比较无复发生存和总生存,Cox比例风险回归估计风险比。

诊断标准与关键数值

  • 匹配后MRI组与无MRI组总复发风险比1.0(P=.99),无显著差异。
  • 匹配后局部区域复发风险比1.3(P=.42),无显著差异。
  • 匹配后对侧乳腺复发风险比0.7(P=.39),无显著差异。
  • 匹配后远处复发风险比0.9(P=.79),无显著差异。
  • 匹配后总生存风险比0.47(P=.07),差异无统计学意义。

临床应用与阅片要点

  • 对35岁及以下乳腺癌患者,术前MRI的生存获益证据有限,阅片和报告时应结合临床需求判断其必要性。

局限性

  • 回顾性研究设计。
  • 单中心或有限中心来源未在摘要中说明,存在选择偏倚可能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background The impact of preoperative breast MRI on the long-term outcomes in patients with breast cancer who are 35 years and younger has not been established. Purpose To evaluate the impact of preoperative breast MRI on recurrence-free survival (RFS) and overall survival (OS) in women with breast cancer who are 35 years and younger by using propensity score matching. Materials and Methods A total of 708 women who were 35 years and younger (mean age, 32 years ± 3 [SD]) and diagnosed with breast cancer from 2007 to 2016 were retrospectively identified. Patients who underwent preoperative MRI (MRI group) were matched with those who did not (no MRI group) according to 23 patient and tumor characteristics. RFS and OS were compared using the Kaplan-Meier method. Cox proportional hazards regression analysis was used to estimate the hazard ratios (HRs). Results Of 708 women, 125 patient pairs were matched. In the MRI group versus the no MRI group, the mean follow-up time was 82 months ± 32 versus 106 months ± 42, and the rates of total recurrence and death were 22% (104 of 478 patients) versus 29% (66 of 230 patients) and 5% (25 of 478 patients) versus 12% (28 of 230 patients), respectively. The time to recurrence was 44 months ± 33 in the MRI group and 56 months ± 42 in the no MRI group. After propensity score matching, the MRI and no MRI groups did not show significant differences in total recurrence (HR, 1.0; P = .99), local-regional recurrence (HR, 1.3; P = .42), contralateral breast recurrence (HR, 0.7; P = .39), or distant recurrence (HR, 0.9; P = .79). The MRI group showed a tendency toward better OS, but this was not statistically significant (HR, 0.47; P = .07). In the entire unmatched cohort, MRI was not an independent significant factor for predicting RFS or OS. Conclusion Preoperative breast MRI was not a significant prognostic factor for recurrence-free survival in women 35 years and younger with breast cancer. A tendency toward better overall survival was observed in the MRI group, but this was not significant. © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Kim and Moy in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Park, Chae, Kim, et al. Effects of Preoperative Breast MRI on Breast Cancer Survival Outcomes in Women Aged 35 Years and Younger. Radiology. 2023. PMID: 36975814. doi:10.1148/radiol.221797

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。